瘤微环境的复杂相互作用甚至在手术后也可以提高胆管癌的进展:一项前性研究
Asmaa M Zahran1, Amal Rayan2, Khaled Saad3
1Clinical Pathology Department, South Egypt Cancer Institute, Assiut University, Assiut, Egypt.
Journal of clinical medicine research
|August 29, 2024
概括
在晚期胆管癌 (CCA) 中,较高的T淋巴细胞水平与更好的结果相关,而巨细胞和PD-1表达量的增加表明预后和治疗反应较差. 这突出了影响CCA进展的关键免疫因素.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 癌症研究 癌症研究
背景情况:
- 胆管癌 (CCA) 呈现出一个复杂的瘤微环境,具有显著的免疫相互作用.
- 了解免疫细胞的作用,如巨细胞和瘤透淋巴细胞 (TILs),对于预测高级CCA的治疗结果至关重要.
- 编程细胞死亡蛋白1 (PD-1) 表达是免疫调节和癌症进展的关键标志物.
研究的目的:
- 研究巨细胞和PD-1表达对晚期CCA患者TILs的影响.
- 确定这些免疫因素与临床病理特征之间的关系.
- 为了将免疫细胞概况与治疗结果相关联,包括无进展生存期 (PFS).
主要方法:
- 招募了25名转移性CCA患者和19名健康对照.
- 使用成像,血清学标记 (CA19-9,CEA) 和手术评估来诊断和分期CCA.
- 对外围血液单核细胞 (PBMC) 的流细胞计分析,以量化CD4+,CD8+,CD4+PD-1+,CD8+PD-1+和CD11b+CD68+巨细胞.
主要成果:
- 与CCA患者相比,对照组的CD4+,CD8+和CD11b+CD68+巨细胞水平较高.
- 在CCA患者中,PD-1表达显著增加.
- CD4+ T-淋巴细胞与改善的PFS相关,而CD8+PD-1+表达与更短的PFS有关. 随着疾病进展和治疗反应较差,巨细胞和PD-1表达增加.
结论:
- 在治疗前,CCA患者的外周免疫格局可以反映系统性免疫状态和治疗反应.
- T淋巴细胞与CCA的更好的预后有关.
- 巨细胞和PD-1表达与晚期胆管癌的不良结果有关,表明它们作为治疗点的潜力.
更多相关视频
09:18Heteromulticellular Stromal Cells in Scaffold-free 3D Cultures of Epithelial Cancer Cells to Drive Invasion
Published on: April 4, 2025
437
07:32Author Spotlight: Investigating Immune Cell Dynamics in the Tumor Microenvironment — Challenges and Innovations in Cancer Prognosis
Published on: April 12, 2024
1.2K
相关概念视频
02:17The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
02:07Tumor Progression
6.3K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.3K
02:30Metastasis
5.5K
Metastasis is the spread of cancer cells from the original site to distant locations in the body. Cancer cells can spread via blood vessels (hematogenous) as well as lymph vessels in the body.
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
Epithelial-to-Mesenchymal Transition
The epithelial-to-mesenchymal transition or EMT is a developmental process commonly observed in wound healing, embryogenesis, and cancer metastasis. EMT is induced by transforming growth factor-beta (TGF-β) or receptor tyrosine kinase (RTK) ligands, which further...
5.5K